Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 177 institutions that hold shares in the stock, with a total of 139 Million shares, which have been reported (via 13F filing form) to have a value of $282 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tpg Gp A, LLC
Fort Worth, TX |
Feb 14, 2025 Q4 2024 |
18,716,306
shares
|
$38.6 Million
1.1% of portfolio
|
Q4 2021
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,445,682
shares
|
$33.9 Million
0.0% of portfolio
|
Q2 2024
Added 70.37%
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
Feb 14, 2025 Q4 2024 |
10,874,723
shares
|
$22.4 Million
9.0% of portfolio
|
Q4 2024
Added 75.33%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
8,000,692
shares
|
$16.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.93%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
7,249,966
shares
|
$14.9 Million
0.0% of portfolio
|
Q4 2024
Added 3.38%
|
|
|
Capital World Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
6,896,552
shares
|
$14.2 Million
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
5,349,096
shares
|
$11 Million
0.0% of portfolio
|
Q4 2024
Added 6.14%
|
|
|
Primecap Management CO
Pasadena, CA |
Feb 10, 2025 Q4 2024 |
4,927,340
shares
|
$10.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 13.07%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
4,485,572
shares
|
$9.24 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.3%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,360,232
shares
|
$8.98 Million
0.07% of portfolio
|
Q4 2024
Reduced 0.09%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
3,736,132
shares
|
$7.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 8.6%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
3,561,626
shares
|
$7.34 Million
0.0% of portfolio
|
Q4 2024
Added 30.44%
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Feb 14, 2025 Q4 2024 |
3,448,275
shares
|
$7.1 Million
3.27% of portfolio
|
Q4 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,232,618
shares
|
$6.66 Million
0.0% of portfolio
|
Q4 2024
Added 0.17%
|
|
|
Wildcat Capital Management, LLC
|
Jan 29, 2025 Q4 2024 |
2,920,787
shares
|
$6.02 Million
2.46% of portfolio
|
Q2 2024
Added 52.06%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
2,867,750
shares
|
$5.91 Million
0.37% of portfolio
|
Q1 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,712,139
shares
|
$5.59 Million
0.01% of portfolio
|
Q4 2024
Reduced 3.07%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
2,702,200
shares
|
$5.57 Million
0.01% of portfolio
|
Q4 2024
Added 12.11%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,106,577
shares
|
$4.34 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.59%
|
|
|
Vida Ventures Advisors, LLC
|
Jan 21, 2025 Q4 2024 |
1,798,163
shares
|
$3.7 Million
4.68% of portfolio
|
Q3 2020
New holding
|
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,500,000
shares
|
$3.09 Million
0.19% of portfolio
|
Q3 2024
Reduced 31.82%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,489,909
shares
|
$3.07 Million
1.19% of portfolio
|
Q4 2024
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,305,232
shares
|
$2.69 Million
0.0% of portfolio
|
Q4 2024
Added 4.54%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
1,240,118
shares
|
$2.55 Million
0.72% of portfolio
|
Q4 2024
Added 18.09%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,188,838
shares
|
$2.45 Million
0.0% of portfolio
|
Q4 2024
Added 0.85%
|